The 4 points where rare disease launches break down
In rare disease launches, every specialist interaction matters. Yet many organizations unintentionally create friction through misaligned priorities,…
Rare disease launches place extraordinary demands on the field. Medical, commercial, and market access teams are often engaging the same small group of specialists, yet without a shared approach, those touchpoints can quickly become fragmented, duplicative, and ineffective. This one pager provides a practical, field‑ready model to align Medical Affairs, Commercial, and Market Access around a single account strategy.
In rare disease launches, every specialist interaction matters. Yet many organizations unintentionally create friction through misaligned priorities,…
When launch budgets shrink, training priorities become even more important. This one-pager outlines a practical framework for…
Most pharma launches fail not because the science is wrong, but because the people delivering it are…
Rare disease launches place extraordinary demands on the field. Medical, commercial, and market access teams are often…